CPSAC
MDT icon

Chas P. Smith & Associates (CPS)’s Medtronic MDT Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
2,837
-200
-7% -$19.2K 0.01% 158
2025
Q4 		$292K Sell
3,037
-2,167
-42% -$210K 0.02% 147
2025
Q3 		$496K Sell
5,204
-1,847
-26% -$170K 0.04% 78
2025
Q2 		$615K Sell
7,051
-1,233
-15% -$105K 0.03% 94
2025
Q1 		$744K Sell
8,284
-351
-4% -$31.4K 0.04% 85
2024
Q4 		$690K Sell
8,635
-1,301
-13% -$113K 0.04% 86
2024
Q3 		$894K Sell
9,936
-1,204
-11% -$101K 0.05% 74
2024
Q2 		$877K Sell
11,140
-2,842
-20% -$233K 0.05% 69
2024
Q1 		$1.22M Sell
13,982
-850
-6% -$72.5K 0.07% 62
2023
Q4 		$1.22M Sell
14,832
-326,971
-96% -$24.9M 0.08% 52
2023
Q3 		$26.8M Sell
341,803
-3,664
-1% -$307K 1.95% 28
2023
Q2 		$30.4M Buy
345,467
+8,148
+2% +$701K 1.96% 26
2023
Q1 		$27.2M Buy
337,319
+13,015
+4% +$1.06M 1.85% 29
2022
Q4 		$25.2M Buy
324,304
+4,498
+1% +$365K 1.79% 30
2022
Q3 		$25.8M Buy
319,806
+13,923
+5% +$1.25M 2.19% 26
2022
Q2 		$27.5M Buy
305,883
+15,976
+6% +$1.62M 1.98% 31
2022
Q1 		$32.2M Buy
289,907
+54,519
+23% +$5.76M 2.43% 24
2021
Q4 		$24.4M Buy
235,388
+7,311
+3% +$847K 1.66% 30
2021
Q3 		$28.6M Buy
228,077
+7,444
+3% +$963K 2.14% 27
2021
Q2 		$27.4M Buy
220,633
+4,748
+2% +$596K 2.13% 26
2021
Q1 		$25.5M Buy
215,885
+8,436
+4% +$989K 2.39% 23
2020
Q4 		$24.3M Buy
207,449
+3,740
+2% +$412K 2.44% 23
2020
Q3 		$21.2M Buy
203,709
+1,110
+0.5% +$111K 2.38% 25
2020
Q2 		$18.6M Buy
202,599
+1,565
+0.8% +$150K 2.26% 27
2020
Q1 		$18.1M Buy
201,034
+48,954
+32% +$5.21M 2.5% 25
2019
Q4 		$17.3M Buy
152,080
+15,627
+11% +$1.71M 1.87% 29
2019
Q3 		$14.8M Buy
136,453
+13,748
+11% +$1.43M 1.71% 30
2019
Q2 		$11.9M Buy
122,705
+120,100
+4,610% +$11M 1.41% 31
2019
Q1 		$237K Buy
+2,605
New +$233K 0.03% 87

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s MDT Position: Q1 2026 in Review

Chas P. Smith & Associates (CPS) reduced its Medtronic (MDT) stake by 6.6% in Q1 2026, selling an estimated $19.2K and leaving 2,837 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #158.

Chas P. Smith & Associates (CPS) first reported a position in MDT in Q1 2019 and has held it in 29 quarters since. The position peaked at $32.2M in Q1 2022. 2,247 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Chas P. Smith & Associates (CPS) held 2,837 shares of Medtronic worth $246K as of Q1 2026.
  • Chas P. Smith & Associates (CPS) sold 200 Medtronic shares in Q1 2026, an estimated $19.2K.
  • Medtronic made up 0.01% of Chas P. Smith & Associates (CPS)'s portfolio in Q1 2026, its #158 holding.
  • Chas P. Smith & Associates (CPS) first reported a position in Medtronic in Q1 2019 and has held it in 29 quarters since.
  • Chas P. Smith & Associates (CPS)'s Medtronic position peaked at $32.2M in Q1 2022.
  • 2,247 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2026, filed 12 May 2026.